Newsroom


Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance

DURHAM, NC – November 9, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today…

Read More

Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs

DURHAM, NC – November 1, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…

Read More

Bioventus Completes the Acquisition of Misonix

DURHAM, NC – October 29, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…

Read More

Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021

DURHAM, NC – October 27, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…

Read More

Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus

DURHAM, NC and FARMINGDALE, NY – October 26, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…

Read More

Bioventus Inc. and Misonix, Inc. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration

DURHAM, NC and FARMINGDALE, NY – October 18, 2021 –Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), today announced an…

Read More

DUROLANE Among High-Molecular Weight Hyaluronic Acid Treatments Linked to Significant Improvements in Knee Osteoarthritis Pain by American Academy of Orthopaedic Surgeons

DURHAM, NC – September 20, 2021 – Bioventus Inc., (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in innovations for active healing, announced…

Read More

Bioventus Proceeds with Option Structure Agreement with CartiHeal

DURHAM, NC – August 30, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…

Read More

Bioventus Invests in Trice Medical Minimally Invasive Technologies

Bioventus Also Agrees to OUS Distribution and Co-Development Relationships DURHAM, NC – August 25, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus”…

Read More

Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer

DURHAM, NC – August 23, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…

Read More

Search News


Media Inquiries


Jamica Whitaker
Communications Manager
919.666.5770
[email protected]

Download Library


Corporate and Brand Logos
Download Now

Product Images
Download Now